Characteristics and Outcomes of US Patients Hospitalized With COVID-19

Ithan D. Peltan, MD, MSc; Ellen Caldwell, MS; Andrew J. Admon, MD, MPH, MSc; Engi F. Attia, MD, MPH; Stephanie J. Gundel, RD; Kusum S. Mathews, MD, MPH, MSCR; Alexander Nagrebetsky, MD, MSc; Sarina K. Sahetya, MD, MHS; Christine Ulysse, MS; Samuel M. Brown, MD, MS; Steven Y. Chang, MD, PhD; Andrew J. Goodwin, MD, MSc; Aluko A. Hope, MD, MSCE; Theodore J. Iwashyna, MD, PhD; Nicholas J. Johnson, MD; Michael J. Lanspa, MD; Lynne D. Richardson, MD; Kelly C. Vranas, MD, MCR; Derek C. Angus, MD, MPH; Rebecca M. Baron, MD; Benjamin A. Haaland, PhD; Douglas L. Hayden, PhD; B. Taylor Thompson, MD; Todd W. Rice, MD, MSc; Catherine L. Hough, MD, MSc


Am J Crit Care. 2022;31(2):146-157. 

In This Article


Among patients hospitalized with COVID-19 early in the pandemic at a geographically diverse network of US hospitals, mortality was 17.7% and was associated with comorbidity burden, male sex, and advancing age. Admission to the ICU, when required, usually occurred within 4 days of hospital arrival. Patients experienced prolonged hospital stays, and a substantial proportion of survivors received new facility-based or home-based health care services or new respiratory support at discharge.